English Chinese Russian German French Japanese Portuguese Hindi Telugu Tamil

Archivos de Medicina

  • ISSN: 1989-5216
  • Índice h de la revista: 22
  • Puntuación de cita de revista: 4.96
  • Factor de impacto de la revista: 4.44
Indexado en
  • Genamics JournalSeek
  • Infraestructura Nacional de Conocimiento de China (CNKI)
  • Directorio de indexación de revistas de investigación (DRJI)
  • OCLC-WorldCat
  • Convocatoria de búsqueda
  • Publón
  • Fundación de Ginebra para la Educación e Investigación Médica
  • pub europeo
  • Google Académico
  • Laboratorios secretos de motores de búsqueda
Ver más
Comparte esta página

Abstracto

Prevalence of Depression among Hospital Based Rheumatoid Arthritis Population and its Associated Factors

Heba Samy Shoukry

Background: Depression is of high prevalence among rheumatoid arthritis patients compromising the physical and psychological aspects of quality of life. It is highly associated with VIT D level.

Patients and methods: This study included 200 RA patients. (BDI) was used to detect depression. Disease activity was measured using disease activity score (DAS-28) and Rheumatoid Arthritis Disease Activity Index (RADAI-5). The Modified Health Assessment Questionnaire (MHAQ) was used for measuring disability. Rheumatoid Arthritis Quality of Life scale (RAQoL), Visual Analogue Score-pain (VAS-pain), and Fatigue Severity Scale (FSS) scores were calculated.

Results: The mean disease duration 6.75 ± 4.32 years, 69.5% were females and 30.5% males (F: M 2.27:1). Their mean DAS-28 was 3.97 ± 1.19 and MHAQ 1.27 ± 0.63. The mean BDI II score was 21 ± 12.61. 48.5% of the patients had moderate depression 4.5% had severe depression. BDI II significantly correlated with erythrocyte sedimentation rate, C-reactive protein, DAS-28, MHAQ, RAQoL VAS-pain FSS and RADAI (p=0.001).

Conclusion: Depression is highly prevalent among rheumatoid arthritis patients. Screening for depression periodically in RA should be included management protocols to avoid poor outcomes.